UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended Commission File Number September 30, 2023 001-39218 CONMED CORPORATION (Exact name of the registrant as specified in its charter) Delaware 16-0977505 (State or other jurisdiction of incorporation or organization) (I ...

CONMED Corporation (NYSE:CNMD) Q2 2023 Earnings Conference Call July 26, 2023 4:30 PM ET Company Participants Curt Hartman - Chairman, President, and CEO Todd Garner - EVP and CFO Conference Call Participants Robert Marcus - JPMorgan Rick Wise - Stifel Matthew O'Brien - Piper Sandler Vik Chopra - Wells Fargo Matthew Mishan - KeyBanc Young Li - Jefferies Kristen Stewart - C.L. King Mike Matson - Needham & Company Operator Before the conference call begins, let me remind you that during this call, management ...

Investor Presentation Q2 2023 Earnings Call ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended Commission File Number June 30, 2023 001-39218 CONMED CORPORATION (Exact name of the registrant as specified in its charter) Delaware 16-0977505 (State or other jurisdiction of incorporation or organization) (I.R.S. ...

Investor Presentation Q1 2023 Earnings Call Curt R. Hartman Chair of the Board, President, and Chief Executive Officer Todd W. Garner Executive Vice President and Chief Financial Officer April 26, 2023 Forward-Looking Information This presentation contains forward-looking statements based on certain assumptions and contingencies that involve risks and uncertainties. The forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995 and rela ...

CONMED Corporation (NYSE:CNMD) Q1 2023 Results Earnings Conference Call April 27, 2023 4:30 PM ET Company Participants Curt Hartman - Chair of the Board, President, and Chief Executive Officer Todd Garner - Executive Vice President and Chief Financial Officer Conference Call Participants Rick Wise - Stifel Financial Lilia-Celine Lozada - J.P. Morgan Ian Tolle - Bank of America Securities Vik Chopra - Wells Fargo Corporate & Investment Banking Matthew O'Brien - Piper Sandler Mike Matson - Needham & Company M ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended Commission File Number March 31, 2023 001-39218 CONMED CORPORATION (Exact name of the registrant as specified in its charter) Delaware 16-0977505 (State or other jurisdiction of incorporation or organization) (I.R.S ...

公司业务概况 - CONMED是一家医疗技术公司，产品用于外科手术，产品线包括骨科手术和普通外科手术[10] - 骨科手术产品线在2022年占总销售额的44%，提供支持运动医学和软组织修复的产品[16] - 普通外科产品线在2022年占总销售额的56%，包括先进的外科和内窥镜技术产品[17] 公司战略 - CONMED的战略包括推出新产品、进行战略收购、实现生产和运营效率、地理多元化和积极参与医疗社区[11][12][13][14][15] 公司国际业务 - CONMED产品在100多个国家销售，国际销售占2022年总净销售额的34%[19] 产品竞争优势 - CONMED在全球骨科和普通外科医疗器械市场竞争，产品线广泛，能够满足各种客户需求和偏好[20] 销售渠道 - CONMED的销售主要通过直接分销到6000多家医院、手术中心和其他医疗机构，以及通过医疗专业分销商进行[21] 研发投入 - 公司研发费用在2022年达到约4,720万美元，较2021年的4,360万美元和2020年的4,050万美元有所增长[23] 知识产权和监管 - 公司拥有知识产权，包括美国专利和外国等效专利，覆盖了公司产品的广泛范围，有效期从2023年到2041年[24] - 公司产品的开发、制造、销售和分销受到多个机构和立法机构的监管，包括美国食品和药物管理局（FDA）和其他国外对应机构[25]

CONMED Corporation (NYSE:CNMD) Q4 2022 Earnings Conference Call February 2, 2023 4:30 PM ET Company Participants Curt Hartman - Chair of the Board, President, and Chief Executive Officer Todd Garner - Executive Vice President and Chief Financial Officer Conference Call Participants Travis Steed - Bank of America Securities Robbie Marcus - JPMorgan Rick Wise - Stifel Matt O'Brien - Piper Sandler Young Li - Jefferies Mike Matson - Needham Matthew Mishan - KeyBanc Operator Good afternoon, everyone. Before the ...

Investor Presentation Curt R. Hartman Chair of the Board, President, and Chief Executive Officer Todd W. Garner Executive Vice President and Chief Financial Officer November 15, 2022 Forward-Looking Information This presentation contains forward-looking statements based on certain assumptions and contingencies that involve risks and uncertainties. The forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995 and relate to the Company's ...